Skip to main navigation

Main Menu
About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers
Amgen Worldwide

All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags

COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities

All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags

COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities

About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers

Breadcrumb

Home
Investors
Reconciliations

Reconciliations

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

05.31.2024

2024 Annual Meeting of Stockholders Presentation 481.6 KB

02.06.2024

Q4 2023 FY Reconciliations 399.2 KB

05.19.2023

2023 Annual Meeting of Stockholders Presentation 559.8 KB

02.14.2023

Non-GAAP Reconciliations - Amgen Fixed Income Investor Presentation February 2023 288.2 KB

05.17.2022

2022 Annual Meeting of Stockholders Presentation 446.2 KB

02.10.2022

Amgen FY21 Non-GAAP Reconciliations 959.2 KB

05.18.2021

2021 Annual Meeting of Stockholders Presentation 306.3 KB

09.18.2020

Form 8937 293.7 KB

05.19.2020

Q4 2019 Financial Results 212.4 KB

Navbar w/ text

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

Earnings

Show all

Q3 2024

Q3 2024 Amgen Earnings Conference Call
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Q3 2024 Earnings Presentation 1.3 MB

Data as of:

Minimum 15 minutes delayed. Source: LSEG

Stay Connected With Amgen.

Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2020 Amgen Inc. All Rights Reserved.